HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease.

AuthorsGaia Mancuso, Tatiana Jofra, Marco Lanzillotta, Alessandro Aiuti, Maria Pia Cicalese, Giulia di Colo, Lorenzo Dagna, Georgia Fousteri, Emanuel Della-Torre
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 60 Issue 8 Pg. 3947-3949 (08 02 2021) ISSN: 1462-0332 [Electronic] England
PMID33856429 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antirheumatic Agents
  • Rituximab
Topics
  • Aged
  • Antirheumatic Agents (therapeutic use)
  • Female
  • Humans
  • Immunoglobulin G4-Related Disease (blood, drug therapy, immunology)
  • Male
  • Middle Aged
  • Prognosis
  • Recurrence
  • Rituximab (therapeutic use)
  • T Follicular Helper Cells (cytology, immunology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: